GPC3 CAR-T (Chinese University Of Hong Kong)

N/A

Report date: 2026/04/22 20:01:10

Base Information

Drug NameGPC3 CAR-T (Chinese University Of Hong Kong)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionAnti-Glypican-3

TargetsGlypican-3

Therapy Area/IndicationsCarcinoma, Hepatocellular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryHong Kong

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesChinese University Of Hong Kong (Cuhk)

China Registration ClassN/A

Develop Information

Active CompaniesChinese University Of Hong Kong (Cuhk)

Inactive CompaniesN/A

Active IndicationsCarcinoma, Hepatocellular

Inactive IndicationsN/A

Other Information

ATC CodeN/A